Squarepoint Ops LLC acquires stake in Tempest Therapeutics
1 report, 1 independent
Updated Oct 11
AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Squarepoint Ops LLC purchased a stake in Tempest Therapeutics on October 11, 2026. This acquisition is being tracked by the Securities and Exchange Commission. Separately, Tempest Therapeutics reported earnings of ($0.34) EPS for the quarter ending August 13, missing the consensus estimate of ($0.30) by ($0.04).
From dailypolitical.com
Why it matters
The purchase by Squarepoint Ops LLC increases institutional ownership in Tempest Therapeutics, which currently holds 22.52% of the stock. This activity occurs while analysts have issued multiple Sell and Hold ratings for the company.
Tempest Therapeutics listed its shares on the Nasdaq electronic stock exchange on July 1, 2026.
From dailypolitical.com
Who's involved
- Securities and Exchange CommissionGovernment agency tracking institutional filings related to the acquisition
Keep exploring
The entities involved
-
Securities and Exchange Commission
government agency of the Philippines